Delivery Order SPE2DB22D2006-SPE2DB25FW2RB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Infed 100 mg/2 mL vials with a ceiling value of $1,922.68. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a non-competitive, non-set-aside procurement, reflecting AmerisourceBergen's established relationship with the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,020.32 to AmerisourceBergen Drug Corp for the supply of Infed 100 mg/2 mL vials. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,030.29 firm-fixed-price delivery order is for the supply of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a performance period extending through June 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $20,214.25 from the Defense Logistics Agency's Medical Supply Chain on September 15, 2025, for the supply of Infed 100 mg/2 mL vials. This firm fixed price, competitively awarded delivery order is expected to be completed by September 16, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, PA. The contract contains no set-aside designation,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Infed 100 mg/2 ml vials. This competitively awarded, non-set-aside contract has a ceiling value of $9,315.83 and an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is...
- This delivery order, awarded August 4, 2025, to AmerisourceBergen Drug Corp represents a $10,075.02 firm fixed-price procurement of Infed 100 mg/2 mL vials for the Defense Department's Medical Supply Chain. The non-competitive delivery order will be performed in Conshohocken, Pennsylvania, with completion scheduled for August 5, 2025. As a child order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with the Defense Logistics Agency for...
- The Defense Logistics Agency Troop Support Medical awarded a $1,274 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561328220 INFED 100 MG/2 ML VIAL 2ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is from June 23, 2023 through June 26, 2023. No additional details were provided regarding the original solicitation or any overarching contracts under which this delivery order was issued. Amerisourcebergen Drug Corporation will fulfill...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product, with a ceiling value of $2,177.10 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products. The total ceiling value of the contract is $8,055.27, and the ultimate completion date is April 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award. The contract does not have a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,628.53 firm fixed-price delivery order by the Defense Logistics Agency on August 29, 2025, for the supply of Injectafer 750 mg/15 mL vials. This non-set-aside, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2RBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,093.02 to AmerisourceBergen Drug Corp on July 19, 2025, for the supply of Infed 100 mg/2 mL vials. The award is a firm fixed price, non-set-aside contract with a completion date of July 21, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a small transaction within the federal medical supply procurement framework supporting military and veteran healthcare systems. This award is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated capability to compete successfully for federal pharmaceutical supply requirements. The company's extensive portfolio with the DLA encompasses a comprehensive range of pharmaceutical products, vaccines, and medical supplies supporting military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 7/19/25 |